New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
15:10 EDTEWEdwards Lifesciences approval for Sapien Xt not far behind, says Jefferies
Jefferies said Edwards Lifesciences (EW) should receive FDA approval for Sapien XT shortly following the early than expected approval of Medtronic's (MDT) TAVR system. The firm reiterates its Buy rating and $72 price target.
News For EW From The Last 14 Days
Check below for free stories on EW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
07:57 EDTEWHouse Energy & Commerce Committee to hold a hearing
The Subcommittee on Health holds a hearing entitled, "21st Century Cures: Examining Barriers to Ongoing Evidence Development and Communication" with CEO Mussallem at Edwards Lifesciences on July 22 at 3 pm. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use